Fluorescence cystoscopy in patients with non-muscle invasive bladder cancer
https://doi.org/10.24931/2413-9432-2015-4-3-29-35
Abstract
The main challenge of treating non-muscle invasive bladder cancer is multifocal tumors. Current methods of diagnosis are failed to detect all superficial flat tumor lesions in bladder mucosa. The use of fluorescence imaging with 5-aminolevulinic acid (5-ALA) allows to improve the sensibility of routine cystoscopy, but low specificity decreases its diagnostic accuracy. The method of fluorescence imaging combined with local fluorescence spectroscopy developed in P.A. Herzen MCRI has been shown to increase the specificity from 71% to 84%. Thus, local fluorescence spectroscopy in visible fluorescence of 5-ALA-induced protoporphyrin allows to perform guided biopsy and decrease the rate of diagnostic mistakes.
About the Authors
I. G. RusakovRussian Federation
A. A. Teplov
Russian Federation
R. V. Ulianov
Russian Federation
E. V. Filonenko
Russian Federation
References
1. Zlokachestvennye novoobrazovaniya v Rossii v 2012 godu (zabolevaemost' i smertnost') (Malignant neoplasms in Russia in 2012 (incidence and mortality)), pod red. Kaprina A.D., Starinskogo V.V., Petrovoi G.V., M. FGBU «MNIOI im. P.A. Gertsena» Minzdrava Rossii, 2014, pp. 1–250.
2. Inoue K., Fukuhara H., Shimamoto T. et al. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer, Cancer, 2012, No. 118 (4), pp. 1062–1074.
3. Dindyal S., Nitkunan T., Bunce C.J. The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer, Photodiagnosis and photodynamic therapy, 2008, No. 5 (2), pp. 153–158.
4. Bordiera B., Mazerollesb C., Malavaud B. Photodynamic diagnosis in non–muscle-invasive bladder cancer, J. Clin. Laser. Med. Surg., 1998, Vol. 16, pp. 61–8.
5. Filonenko E.V. Fluorestsentnaya diagnostika i fotodinamicheskaya terapiya – obosnovanie primeneniya i vozmozhnosti v onkologii (Fluorescence diagnosis and photodynamic therapy – justification of use and opportunities in oncology), Fotodinamicheskaya terapiya i fotodiagnostika, 2014, No. 1, pp. 3–7.
6. Datta S.N., Loh C.S., MacRobert A.J. et.al. Quantitative studies of the kinetics of 5- aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma, Br. J. Cancer, 1998, Vol. 78, pp. 1113–1118.
7. Zaak D., Frimberger D., Stepp H. et al. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection, J. Urol., 2001, Vol. 166, pp. 1665–1669.
8. Frimberger D., Zaak D., Stepp H. et.al. Autofluorescence imaging to optimize 5-ALA-induced fluorescence endoscopy of bladder carcinoma, Urology, 2001, Vol. 58, pp. 372–375.
9. Filonenko E.V. Fluorestsentnaya diagnostika i fotodinamicheskaya terapiya v onkologii (Fluorescence diagnosis and photodynamic therapy in oncology). Dis. d.m.n. M., 2006, pp. 1–195.
Review
For citations:
Rusakov I.G., Teplov A.A., Ulianov R.V., Filonenko E.V. Fluorescence cystoscopy in patients with non-muscle invasive bladder cancer. Biomedical Photonics. 2015;4(3):29-35. (In Russ.) https://doi.org/10.24931/2413-9432-2015-4-3-29-35